A Dramatic Day for Dendreon - BusinessWeek


Xinhua		 A Dramatic Day for Dendreon
BusinessWeek -8 hours ago
Dendreon's (DNDN) stock price surged nearly 150% on Mar. 30 after news that the US Food and Drug Administration advisory committee vouched for the company's Provenge compound - even though the prostate cancer treatment may not kill tumors.
Big step forward for cancer vaccineSan Francisco Chronicle
FDA panel Oks prostate drugLos Angeles Times
International Herald Tribune - WebMD - Forbes - Bloomberg
all 369 news articles

More: continued here

Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • De.lirio.us
  • digg
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Shadows
  • Simpy
  • Smarking
  • Spurl
  • YahooMyWeb



   Posted in Health News    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.





No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment